Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**AMRUTANJAN HEALTH CARE LIMITED – Financial Risk Summary** Amrutanjan's largest financial exposure is compliance risk (scored 10/10), with estimated remediation costs of ₹1–3 crore under SEBI BRSR Core Expansion mandates, including non-disclosure of Scope 1 and Scope 2 emissions data—a critical gap that invites regulatory scrutiny and potential enforcement action. Extended Producer Responsibility (EPR) exposure at 6.5/10 presents secondary but material risk, as the company has not clarified EPR applicability across its pharmaceutical and beverage product lines, creating uncertainty around future collection and recycling obligations. The company faces immediate pressure to complete comprehensive GHG accounting and environmental disclosures under BRSR P6 standards; failure to comply risks SEBI enforcement penalties and potential delisting consequences for top-tier listed entities. Water intensity risk (5.0/10) and governance deficiencies compound exposure, particularly given the beverage segment's water dependency, requiring urgent disclosure framework implementation and third-party assurance to mitigate market and regulatory penalties.
Source: AMRUTANJAN HEALTH CARE LIMITED BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.